JG
ANIP icon

Joel Greenblatt’s ANI Pharmaceuticals ANIP Stock Holding History

Joel Greenblatt’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Sell
6,027
-18,068
-75% -$1.45M ﹤0.01% 1515
2026
Q1 		$1.85M Sell
24,095
-8,747
-27% -$683K 0.01% 1131
2025
Q4 		$2.59M Buy
32,842
+24,254
+282% +$2.1M 0.01% 968
2025
Q3 		$787K Buy
+8,588
New +$700K ﹤0.01% 1276
2024
Q3 		– Sell
-4,929
Closed -$314K – 1413
2024
Q2 		$314K Sell
4,929
-2,821
-36% -$183K ﹤0.01% 1213
2024
Q1 		$536K Sell
7,750
-1,519
-16% -$91.7K 0.01% 1023
2023
Q4 		$511K Buy
9,269
+4,165
+82% +$229K 0.01% 984
2023
Q3 		$296K Buy
+5,104
New +$295K 0.01% 1123
2018
Q4 		– Sell
-14,451
Closed -$817K – 975
2018
Q3 		$817K Sell
14,451
-1,511
-9% -$92.5K 0.01% 643
2018
Q2 		$1.07M Buy
+15,962
New +$996K 0.02% 582
2017
Q1 		– Sell
-4,137
Closed -$251K – 985
2016
Q4 		$251K Sell
4,137
-626
-13% -$38.3K ﹤0.01% 845
2016
Q3 		$316K Sell
4,763
-2,561
-35% -$160K ﹤0.01% 773
2016
Q2 		$409K Sell
7,324
-4,364
-37% -$212K ﹤0.01% 759
2016
Q1 		$393K Buy
+11,688
New +$396K ﹤0.01% 800
2015
Q4 		– Sell
-24,801
Closed -$980K – 864
2015
Q3 		$980K Buy
24,801
+11,743
+90% +$668K 0.01% 622
2015
Q2 		$810K Sell
13,058
-25,621
-66% -$1.52M 0.01% 668
2015
Q1 		$2.42M Buy
38,679
+34,594
+847% +$2.1M 0.02% 501
2014
Q4 		$230K Buy
+4,085
New +$180K ﹤0.01% 892

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Joel Greenblatt's ANIP Position: Q2 2026 in Review

Joel Greenblatt reduced its ANI Pharmaceuticals (ANIP) stake by 75% in Q2 2026, selling an estimated $1.45M and leaving 6,027 shares worth $499K. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

Joel Greenblatt first reported a position in ANIP in Q4 2014 and has held it in 18 quarters since. The position peaked at $2.59M in Q4 2025. 305 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Joel Greenblatt held 6,027 shares of ANI Pharmaceuticals worth $499K as of Q2 2026.
  • Joel Greenblatt sold 18,068 ANI Pharmaceuticals shares in Q2 2026, an estimated $1.45M.
  • ANI Pharmaceuticals made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1515 holding.
  • Joel Greenblatt first reported a position in ANI Pharmaceuticals in Q4 2014 and has held it in 18 quarters since.
  • Joel Greenblatt's ANI Pharmaceuticals position peaked at $2.59M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.